Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002077 · ClinicalTrials.gov registry record · NA
An Open, Non-Comparative Study of Intravenous and Oral Fluconazole in the Treatment of Acute Cryptococcal Meningitis
A NA study, sponsored by Pfizer.
- Completed
- Registry status
- NA
- Development phase
NCT00002077: Completed NA study, sponsored by Pfizer.
NCT00002077 is a NA study that has completed, run by Pfizer. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00002077, a NA study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
To evaluate the safety and effectiveness of fluconazole as an intravenous dose as initial treatment for acute cryptococcal meningitis followed by oral therapy in AIDS and non-AIDS patients. Lack of satisfactory response will allow increase of dose. Both newly diagnosed and relapsed patients are eligible.
Interventions
- DRUG Fluconazole
Trial Details
| Field | Value |
|---|---|
| Phase | NA |
What the finished NCT00002077 record still lists
NCT00002077 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Fluconazole is the first listed.
NCT00002077 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00002077 about?
NCT00002077 is a clinical study titled "An Open, Non-Comparative Study of Intravenous and Oral Fluconazole in the Treatment of Acute Cryptococcal Meningitis". To evaluate the safety and effectiveness of fluconazole as an intravenous dose as initial treatment for acute cryptococcal meningitis followed by oral therapy in AIDS and non-AIDS patients. Lack of satisfactory response will allow increase of dose. Both newly diagnosed and relapsed patients are elig...
What is the current status of trial NCT00002077?
This trial is currently completed. It is a NA study.
What interventions are being tested in trial NCT00002077?
The interventions under investigation include: Fluconazole (DRUG).
Who is sponsoring clinical trial NCT00002077?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.